pre-seed
Stage
1
Investors
About
Cytok is a German biotech company developing innovative allogeneic CAR-T cell therapies for cancer patients. Their lead product, CYT-101, is designed to target solid tumors.
Explore Cytok's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.